Resources

Publications

Assessing the utility of the tipping point ratio to monitor HIV treatment programme in the era of universal access to ART

Simon de Montigny, Marie-Claude Boily, Benoît Mâsse, Kate M Mitchell, Dobromir Dimitrov

Infectious Disease Modelling, 3: 85-96 (2018)

Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study

Kate M Mitchell, Holly J Prudden, Reynold Washington, Shajy Isac, Subramanian P Rajaram, Anna M Foss, Fern Terris-Prestholt, Marie-Claude Boily, Peter Vickerman

Journal of the International AIDS Society, 19:20942 (2016)

PrEP adherence patterns strongly impact individual HIV risk and observed efficacy in randomized clinical trials

Dobromir T. Dimitrov, Benoît R. Mâsse, Deborah Donnell

JAIDS 72(4):444-451 (2016)

A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population

Dobromir Dimitrov, Hans-Peter Kiem, Keith R. Jerome, Christine Johnston, Joshua T. Schiffer

Scientific Reports. 6:22183 (2016)

How much do we know about drug resistance due to PrEP use? Analysis of experts’ opinion and its influence on the projected public health impact.

Dobromir T. Dimitrov, Marie-Claude Boily, Timothy B. Hallett, Jan Albert, Charles Boucher, John W. Mellors, Deenan Pillay, David A.M.C. van de Vijver

PLoS ONE 11(7): e0158620 (2016)

High incidence is not high exposure: What proportion of prevention trial participants are exposed to HIV?

Dobromir Dimitrov, Deborah Donnell, Elizabeth R. Brown

PLoS ONE 10(1): e0115528 (2015)

See all Publications

Presentations

ICASA 2015 – 18th International Conference on AIDS and STIs in Africa (Zimbabwe)

Modeling HIV transmission and prevention in Côte d’Ivoire: impacts of a national accelerated response plan… read more
R4P 2014 – HIV Research for Prevention (Cape Town)

Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact of Drug… read more
CAHR 2016 – 25th Annual Canadian Conference on HIV/AIDS Research (Winnipeg)

In What Circumstances Could Non-daily Pre-exposure Prophylaxis (PrEP) Substantially Reduce Program Costs (HPTN 067)? Kate… read more
R4P 2018 – HIV Research for Prevention (Madrid)

Potential Impact of increased ART and PrEP coverage on the HIV Epidemic among MSM in… read more
ISI 2017 – 61st ISI World Statistics Congress (Marrakech)

Analysis of the Impact of the heterogeneity in exposure to HIV on the results of… read more
NHPC 2015 – National HIV Prevention Conference (Atlanta)

PrEP adherence patterns strongly impact individual HIV risk and observed efficacy in clinical trials [… read more

See all Presentations

Meetings/workshops

HPTN annual meeting 2017 (Washington DC)

Modelling plenary: Cost-effectiveness of financial incentives for viral suppression. An Economic Model of HPTN 065. Blythe… read more
Global HIV Vaccine Enterprise 2017

Impact and cost-effectiveness of HIV prevention: Data inputs for HIV models and how they inform HIV… read more
HPTN annual meeting 2016 (Washington DC)

HPTN Modelling Center Plenary Introducing HPTN Modelling Centre: Who? What? When? How? Marie-Claude Boily Loading... Taking too long?… read more
HPTN annual meeting 2015 (Washington DC)

Plenary: The promise of PrEP among key populations in concentrated HIV epidemics Kate M. Mitchell… read more
NIH RAPIDD Workshop (2015) on : integrating mathematical models with the design and analysis of clinical trials to assess the efficacy of disease prevention and control interventions (Seattle)

The Role of Mathematical Modelling to Design, Conduct, Interpret and Replicate HIV Prevention Trials Dobromir… read more
HPTN annual meeting 2014 (Washington DC)

Plenary: Modelling the impact of different patterns of adherence to PrEP on the observed efficacy… read more

See all Meetings/workshops